PUBLIC CONTRACT · 2022
Imunomoduladores - Adalimumab 40 mg/0.8 ml
- Contract value
- €39,780.00
- Signed on
- 3 February 2022
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9122509PUBLISHED SUBJECT
IMUNOMODULADORES - ADALIMUMAB 40 MG/0.8 ML
Parties involved
- Awardee
- - - BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL
- Place of performance
- Portugal, Região Autónoma da Madeira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL
- Bidder
- BIOGEN IDEC PORTUGAL, LDA · Tax ID 506415740
Values and timeline
- Contract price
- €39,780.00
- Procedure base price
- €39,780.00
- Total effective price
- €32,400.00
- Publication date
- 17 March 2022
- Award date
- 3 February 2022
- Signing date
- 3 February 2022
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Multifator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017) e Lei n.º 30/2021, de 21.05 e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5474248
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.